SOC

Crowdbotics Achieves SOC 2 Type 1 Compliance Certification

Retrieved on: 
Thursday, November 30, 2023

Becoming SOC 2 certified involves rigorous requirements on how an organization handles customer data and information, and compliance ensures that organizational practices are established, implemented and in place to protect customer data.

Key Points: 
  • Becoming SOC 2 certified involves rigorous requirements on how an organization handles customer data and information, and compliance ensures that organizational practices are established, implemented and in place to protect customer data.
  • Crowdbotics is reimagining the software development lifecycle by making it faster than ever to build complete, scalable apps for business.
  • SOC 2 certification assures Crowdbotics customers that its platform meets the security, availability, and confidentiality standards defined by the American Institute of CPAs (AICPA).
  • The company will now pursue Type 2 certification, which tests the effectiveness of controls over a period of time.

Applied Systems Achieves SOC 1 Type II Compliance

Retrieved on: 
Wednesday, November 29, 2023

Chicago, IL., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Applied Systems® today announced that it has achieved SOC 1 Type II compliance for Applied Epic®.

Key Points: 
  • Chicago, IL., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Applied Systems® today announced that it has achieved SOC 1 Type II compliance for Applied Epic®.
  • SOC 1 Type II compliance is highly regarded in the financial services industry and recognized by businesses of all sizes as a standard for security and compliance.
  • The SOC 1 Type II audit was conducted by CyberGuard Compliance, LLP, a leading independent auditing firm.
  • “We are proud to achieve SOC 1 Type II compliance for Applied Epic, providing our customers more security controls and helping lower their security-related costs,” said Tanner Randolph, chief information security officer, Applied Systems.

TRIMEDX receives International Organization for Standardization’s world-class information management security recertification

Retrieved on: 
Tuesday, November 28, 2023

Indianapolis, Indiana, Nov. 28, 2023 (GLOBE NEWSWIRE) -- TRIMEDX ―an industry-leading, independent clinical asset management company delivering clinical engineering services, clinical asset informatics, and medical device cybersecurity―has been recertified with the highly regarded International Organization for Standardization’s Information Management Security certification ISO/IEC 27001:2013, a widely recognized international standard outlining best practices for information security management.

Key Points: 
  • Indianapolis, Indiana, Nov. 28, 2023 (GLOBE NEWSWIRE) -- TRIMEDX ―an industry-leading, independent clinical asset management company delivering clinical engineering services, clinical asset informatics, and medical device cybersecurity―has been recertified with the highly regarded International Organization for Standardization’s Information Management Security certification ISO/IEC 27001:2013, a widely recognized international standard outlining best practices for information security management.
  • This recertification, valid through Dec. 2026, reverifies that TRIMEDX meets the latest information security industry standards while maintaining and enforcing policies and procedures to ensure the security of data.
  • Meeting the standard demonstrates TRIMEDX’s achievement of world-class safety and security management of information.
  • The ISO 27001 certification couples with TRIMEDX’s Service Organization Control (SOC) 2 Type 2 and ISO 13485:2016 certification (valid through Aug. 2024) to make up TRIMEDX’s Quality Management System covering MD QMS and Information Security Management System (ISMS) standards.

Arteris Celebrates 3ʳᵈ Year of Automotive ISO 26262 TCL1 Functional Safety Compliance for Magillem SoC Integration Automation

Retrieved on: 
Tuesday, November 28, 2023

This milestone expands upon Arteris’ ongoing commitment to delivering functional safety capabilities for mission-critical applications across the entire product portfolio.

Key Points: 
  • This milestone expands upon Arteris’ ongoing commitment to delivering functional safety capabilities for mission-critical applications across the entire product portfolio.
  • ISO 26262 is an internationally recognized standard for ensuring functional safety in the automotive industry.
  • It establishes comprehensive guidelines for designing and testing electrical and electronic systems in vehicles, ultimately reducing risks and accidents associated with automotive technology.
  • “Arteris’ Magillem SoC integration automation software continues to meet the rigorous requirements of ISO 26262 TCL1, which in turn allows their customers to reduce the time spent on tool qualification and focus instead on product development.”
    “We are pleased that Arteris’ Magillem SoC integration products recently passed their annual factory inspection, which reaffirms their sustained level of high-quality development demanded by ISO 26262 TCL1,” said Stefano Lorenzini, functional safety fellow at Arteris.

Continuous Improvement Strategy Changes the Game (and the Name!) for United Direct Solutions

Retrieved on: 
Tuesday, November 21, 2023

Founded in 1980, United Direct Solutions’ directive has remained unchanged: to enrich connections between companies and their audiences.

Key Points: 
  • Founded in 1980, United Direct Solutions’ directive has remained unchanged: to enrich connections between companies and their audiences.
  • With locations in Louisville, KY, and Cincinnati, OH, United Direct Solutions serves small-to-medium businesses and Fortune 500 companies nationwide.
  • Casey applies the same “continuous improvement” philosophy to United Direct Solutions’ company culture.
  • “I cannot agree more with the high priority Casey puts on cultivating United Direct Solutions’ culture.

Plus Therapeutics Reports New Interim ReSPECT-GBM Phase 2 Trial Data at the Society for NeuroOncology Annual Meeting and will Host Key Opinion Leader Webinar

Retrieved on: 
Monday, November 20, 2023

The Company is hosting a virtual key opinion leader (KOL) webinar to discuss the data today at 10:00 am ET.

Key Points: 
  • The Company is hosting a virtual key opinion leader (KOL) webinar to discuss the data today at 10:00 am ET.
  • Rhenium (186Re) obisbemeda continues to be generally safe and well tolerated, consistent with data accumulated in the Phase 1 trial.
  • Plus Therapeutics is hosting a virtual KOL event today, November 20, 2023 at 10:00 am ET to discuss the data presented at SNO.
  • A replay of the event will be available on Investor Relations section of the Plus Therapeutics website after the event.

Weebit Nano’s ReRAM IP achieves high temperature qualification in SkyWater Technology’s S130 process

Retrieved on: 
Monday, November 20, 2023

This qualification, based on a one-transistor one-resistor (1T1R) memory module leverages the previous qualification of Weebit ReRAM IP at these temperatures and is now ready for production tapeout at SkyWater.

Key Points: 
  • This qualification, based on a one-transistor one-resistor (1T1R) memory module leverages the previous qualification of Weebit ReRAM IP at these temperatures and is now ready for production tapeout at SkyWater.
  • Such qualification demonstrates the quality and repeatability of Weebit’s embedded ReRAM IP for applications requiring high-temperature reliability.
  • The S130 process by SkyWater is a silicon proven mixed-signal CMOS platform targeting automotive and industrial applications.
  • We are delighted to mark another qualification milestone with Weebit.”
    The Weebit ReRAM IP module is available with full support in SkyWater’s S130 process design kit.

U.S. FDA Approves Label Update for Kite’s Yescarta® CAR T-Cell Therapy to Include Overall Survival Data

Retrieved on: 
Thursday, December 21, 2023

The label update is based on results from the ZUMA-7 study which demonstrated a 27.4% reduction in the risk of death with Yescarta versus SOC, a relative 38% improvement in OS.

Key Points: 
  • The label update is based on results from the ZUMA-7 study which demonstrated a 27.4% reduction in the risk of death with Yescarta versus SOC, a relative 38% improvement in OS.
  • The estimated 39-month OS rates were 55.9% in the Yescarta arm and 46% in the SOC arm.
  • “Our ZUMA-7 overall survival analysis proves that when given as second-line therapy, Yescarta is even more effective in improving patient survival than standard of care treatment.
  • *Treatment of curative intent is a line of treatment administered with the goal of achieving a durable complete response/ remission.

Strategic Organizing Center Comments on Starbucks’ Recent Efforts to Reframe its Track Record of Human Capital Mismanagement

Retrieved on: 
Wednesday, December 20, 2023

Joshua Gotbaum and Wilma Liebman – for election to the Starbucks Board of Directors (the “Board”) at the upcoming 2024 Annual Meeting of Shareholders (the “Annual Meeting”).

Key Points: 
  • Joshua Gotbaum and Wilma Liebman – for election to the Starbucks Board of Directors (the “Board”) at the upcoming 2024 Annual Meeting of Shareholders (the “Annual Meeting”).
  • The SOC is a coalition of labor unions, including the Service Employees International Union (“SEIU”).
  • Notably, Starbucks’ own report, released on December 13, 2023, states that the Company did not understand or give consideration to its labor rights commitments in the context of recent organizing.
  • Since November 2021, the NLRB has issued over 120 complaints against Starbucks, covering about 420 charges of violating federal labor law.

SANS Institute Research Shows What Frameworks, Benchmarks, and Techniques Organizations Use on their Path to Security Maturity

Retrieved on: 
Tuesday, December 19, 2023

Expel , the security operations provider that aims to make security easy to understand, use and improve, today released a new research report, “ Frameworks, Tools and Techniques: The Journey to Operational Security Effectiveness and Maturity ” by the SANS Institute.

Key Points: 
  • Expel , the security operations provider that aims to make security easy to understand, use and improve, today released a new research report, “ Frameworks, Tools and Techniques: The Journey to Operational Security Effectiveness and Maturity ” by the SANS Institute.
  • View the full release here: https://www.businesswire.com/news/home/20231219800122/en/
    Expel-commissioned research unveils what frameworks, benchmarks, and techniques organizations use on their path to security maturity.
  • “Not enough respondents’ organizations have executive-level governance, and too many are missing well-defined training programs.
  • The SANS Institute conducted a comprehensive online survey of IT and cybersecurity professionals from private- and public-sector organizations across industries and geographies between August 2023 and September 2023.